Logo image of CYT

CYTEIR THERAPEUTICS INC (CYT) Stock Analyst Ratings

NASDAQ:CYT - Nasdaq - US23284P1030 - Common Stock - Currency: USD

3.02  -0.07 (-2.27%)

After market: 3.1 +0.08 (+2.65%)

Buy % Consensus

45

ChartMill assigns a Buy % Consensus number of 45% to CYT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 1.32% above the current price.
CYT was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about CYT.
In the previous month the buy percentage consensus was at a similar level.
CYT was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

CYT Historical Analyst RatingsCYT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 3.023.033.063.063.15 - 0.33% 1.32% 1.32% 4.30%

Related screens

CYT Current Analyst RatingCYT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-01-05 B of A Securities Downgrade Neutral -> Underperform
2023-05-12 Wedbush Reiterate Outperform -> Outperform
2023-02-03 Morgan Stanley Downgrade Equal-Weight -> Underweight
2023-01-30 B of A Securities Downgrade Buy -> Neutral
2023-01-20 JP Morgan Downgrade Overweight -> Neutral
2022-09-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-02-07 Northland Capital Markets Initiate Outperform
2021-07-13 Wedbush Initiate Outperform
2021-07-13 JP Morgan Initiate Overweight
2021-07-13 B of A Securities Initiate Buy
2021-07-13 Morgan Stanley Initiate Overweight